Alpha‐kinase 1 (ALPK1) agonist DF‐006 demonstrates potent efficacy in mouse and primary human hepatocyte (PHH) models of hepatitis B
In: Hepatology, Jg. 77 (2023), Heft 1, S. 275-289
serialPeriodical
Zugriff:
Titel: |
Alpha‐kinase 1 (ALPK1) agonist DF‐006 demonstrates potent efficacy in mouse and primary human hepatocyte (PHH) models of hepatitis B
|
---|---|
Autor/in / Beteiligte Person: | Xu, Cong ; Fan, Jieqing ; Liu, Danyang ; Tuerdi, Aimaier ; Chen, Juanjuan ; Wei, Yuning ; Pan, Yanfang ; Dang, Huaixin ; Wei, Xiong ; Yousif, Ashraf Siddig ; Yogaratnam, Jeysen ; Zhou, Qiong ; Lichenstein, Henri ; Xu, Tian |
Link: | |
Zeitschrift: | Hepatology, Jg. 77 (2023), Heft 1, S. 275-289 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 0270-9139 (print) |
Sonstiges: |
|